{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T13:15:05Z","timestamp":1777209305211,"version":"3.51.4"},"reference-count":118,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1053\/bega.2000.0146","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"1049-1073","source":"Crossref","is-referenced-by-count":12,"title":["Liver transplantation of patients in end-stage cirrhosis"],"prefix":"10.1053","volume":"14","author":[{"given":"Geoffrey H.","family":"Haydon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.2000.0146_RF1","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1097\/00007890-199712270-00030","article-title":"Ten years of liver transplantation","volume":"64","author":"Abbasoglu","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF2","first-page":"15","article-title":"Long-term patient and retransplantation survival by selected recipient and donor characteristics: an update from the Pitt-UNOS liver transplant registry","volume":"18","author":"Seaberg","year":"1997","journal-title":"Clinical Transplantation"},{"key":"10.1053\/bega.2000.0146_RF3","doi-asserted-by":"crossref","first-page":"VI1","DOI":"10.1136\/gut.45.2008.vi1","article-title":"Indications for referral and assessment in adult liver transplantation: a clinical guideline","volume":"45","author":"Devlin","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0146_RF4","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/00007890-199810150-00034","article-title":"Minimal criteria for placement of adults on the liver transplant waiting list","volume":"66","author":"Lucey","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00007890-199901270-00010","article-title":"Evolving trends in liver transplantation","volume":"67","author":"Gilbert","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0025-7125(16)30651-4","article-title":"Liver transplantation","volume":"73","author":"Munoz","year":"1989","journal-title":"Medical Clinics of North America"},{"key":"10.1053\/bega.2000.0146_RF7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/gut.20.2.137","article-title":"Serum bilirubin: a prognostic factor in primary biliary cirrhosis","volume":"20","author":"Shapiro","year":"1979","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0146_RF8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/gut.31.9.1069","article-title":"Referral of patients with primary biliary cirrhosis for liver transplantation","volume":"31","author":"Neuberger","year":"1990","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0146_RF9","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJM198906293202602","article-title":"Efficacy of liver transplantation in patients with primary biliary cirrhosis","volume":"320","author":"Markus","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostifactors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","article-title":"Primary sclerosing cholangitis: liver transplantation or biliary surgery","volume":"117","author":"Farges","year":"1995","journal-title":"Surgery"},{"key":"10.1053\/bega.2000.0146_RF12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.510230526","article-title":"Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation","volume":"25","author":"Nashan","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicentre case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF14","first-page":"1124","article-title":"Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after transplantation","volume":"25","author":"Abu-Elmagd","year":"1993","journal-title":"Transal Proc"},{"key":"10.1053\/bega.2000.0146_RF15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/annonc\/10.suppl_4.S221","article-title":"Conformal irradiation for hepatobiliary malignancies","volume":"10","author":"Gunderson","year":"1999","journal-title":"Annals of Oncology"},{"key":"10.1053\/bega.2000.0146_RF16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199603283341302","article-title":"Long-term outcome of hepatitis C virus infection after liver transplantation","volume":"334","author":"Gane","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/gast.1996.v110.pm8536853","article-title":"A longitudinal analysis of hepatitis C viral replication following liver transplantation","volume":"110","author":"Gane","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0016-5085(95)90207-4","article-title":"Influence of genotypes on the severity of recurrent liver disease after liver transplantation","volume":"108","author":"Feray","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/lt.500030504","article-title":"Hepatitis C virus genotypes and quantitation of serum hepatitis C virus RNA in liver transplantation recipients: relationship with severity of histological recurrence and implications in the pathogenesis of HCV infection","volume":"3","author":"Pageaux","year":"1997","journal-title":"Liver Transplant Surgery"},{"key":"10.1053\/bega.2000.0146_RF20","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.42.5.744","article-title":"Outcome of orthotopic liver transplantation in patients with haemophilia","volume":"42","author":"Gordon","year":"1998","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0146_RF21","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications","volume":"14","author":"O'Grady","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF22","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF23","first-page":"813","article-title":"Liver transplantation in HbsAg positive patients; a European experience 1977\u20131990","volume":"329","author":"Samuel","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomised trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bmj.301.6742.15","article-title":"Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse","volume":"301","author":"Bird","year":"1990","journal-title":"British Medical Journal"},{"key":"10.1053\/bega.2000.0146_RF27","first-page":"105","article-title":"Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease","volume":"20","author":"Osorio","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF28","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(92)91737-O","article-title":"Selection for and outcome of liver transplantation in alcoholic liver disease","volume":"102","author":"Lucey","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","author":"Prados","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840200221","article-title":"Outcome of liver transplantation in patients with haemochromatosis","volume":"20","author":"Farrell","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF31","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/lt.500010408","article-title":"Primary liver cancer and survival in patients undergoing liver transplantation for haemochromatosis","volume":"1","author":"Kowdley","year":"1995","journal-title":"Liver Transplantation and Surgery"},{"key":"10.1053\/bega.2000.0146_RF32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/clinids\/19.5.854","article-title":"An observational study of 11 French liver transplant recipients infected with human immunodeficiency virus type 1","volume":"19","author":"Bouscarat","year":"1994","journal-title":"Clinical Infectious Disease"},{"key":"10.1053\/bega.2000.0146_RF33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJM198702193160814","article-title":"Liver transplantation in older patients","volume":"316","author":"Starzl","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF34","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0140-6736(99)90002-8","article-title":"Guidelines for selection of patients for liver transplantation in the era of donor shortage","volume":"354","author":"Neuberger","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-1007196","article-title":"Pathogenesis of ascites in cirrhosis","volume":"17","author":"Gines","year":"1997","journal-title":"Seminars in Liver Disease"},{"key":"10.1053\/bega.2000.0146_RF36","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind placebo-controlled trial","volume":"12","author":"Gines","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF37","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.1840050320","article-title":"Oral non-absorbable antibiotics prevent infection in cirrhotics with gastrointestinal haemorrhage","volume":"5","author":"Rimola","year":"1985","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF38","unstructured":"Soriano, G, Guarner, C, Tomas, A, Norfloxacin prevents bacterial infection in cirrhotics with gas"},{"key":"10.1053\/bega.2000.0146_RF39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2165\/00003495-199243030-00003","article-title":"Pharmacotherapy of ascites associated with cirrhosis","volume":"43","author":"Gines","year":"1992","journal-title":"Drugs"},{"key":"10.1053\/bega.2000.0146_RF40","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00000658-199803000-00017","article-title":"Liver transplantation complicated by misplaced TIPSS in the portal vein","volume":"227","author":"Clavien","year":"1998","journal-title":"Annals of Surgery"},{"key":"10.1053\/bega.2000.0146_RF41","series-title":"Oxford Textbook of Clinical Hepatology","first-page":"1923","article-title":"Nutritional aspects of liver and biliary disease","author":"Morgan","year":"1999"},{"key":"10.1053\/bega.2000.0146_RF42","first-page":"A55","article-title":"Central venous cannulation in patients with liver disease and disordered haemostasis\u2014a prospective audit","volume":"44","author":"Fisher","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.2000.0146_RF43","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00007890-199604150-00013","article-title":"Graft function and outcome of older donor livers","volume":"61","author":"Washburn","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(99)80018-X","article-title":"Indocyanine green clearance reflects reperfusion injury following liver transplantation and is an early predictor of graft function","volume":"30","author":"Plevris","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/bjs.1800740103","article-title":"Orthotopic liver transplantation: postoperative complications and their outcome","volume":"74","author":"Kirby","year":"1987","journal-title":"British Journal of Surgery"},{"key":"10.1053\/bega.2000.0146_RF46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/lt.500020214","article-title":"Is hepatic histology the true gold standard in diagnosing acute allograft rejection?","volume":"2","author":"Wiesner","year":"1996","journal-title":"Liver Transplant Surgery"},{"key":"10.1053\/bega.2000.0146_RF47","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff scheme for grading liver allograft rejection: an international consensus document","volume":"25","author":"Demetris","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0168-8278(98)80163-3","article-title":"Is acute rejection deleterious to long-term liver allograft rejection?","volume":"29","author":"Dousset","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF49","first-page":"55","article-title":"High dose acyclovir compared with short-course pre-emptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients","volume":"127","author":"Singh","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0146_RF50","first-page":"S64","article-title":"Use of antilymphocyte induction therapy in liver transplantation","volume":"5","author":"Wall","year":"1999","journal-title":"Liver Transplantation Surgery"},{"key":"10.1053\/bega.2000.0146_RF51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.1840060519","article-title":"Prognostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation","volume":"6","author":"Cuervas-Mons","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1432-2277.1993.tb00755.x","article-title":"Infections in human liver recipients: different patterns early and late","volume":"6","author":"Barkholt","year":"1993","journal-title":"Transplantation International"},{"key":"10.1053\/bega.2000.0146_RF53","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/hep.1840210517","article-title":"Bacterial and fungal infection after liver transplantation: an analysis of 284 patients","volume":"21","author":"Wade","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/hep.1840060329","article-title":"Adult liver transplantation: an analysis of the early causes of death in 40 consecutive cases","volume":"6","author":"Cuervas-Mons","year":"1986","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/clinids\/13.3.387","article-title":"Bacterial infection as a complication of liver transplantation: epidemiology and risk factors","volume":"13","author":"George","year":"1991","journal-title":"Reviews in Infectious Disease"},{"key":"10.1053\/bega.2000.0146_RF56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007890-199802270-00008","article-title":"Orthotopic liver transplantation in high risk patients; risk factors associated with mortality and infectious morbidity","volume":"27","author":"Gayowski","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF57","first-page":"2420","article-title":"Selective bowel decontamination to prevent Gram-negative bacterial and fungal infection following orthotopic liver transplantation","volume":"19","author":"Wiesner","year":"1987","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00003246-199401000-00011","article-title":"Selective decontamination of the digestive tract reduces Gram-negative pulmonary colonisation but not systemic endotoxaemia in patients undergoing elective liver transplantation","volume":"22","author":"Bion","year":"1994","journal-title":"Critical Care Medicine"},{"key":"10.1053\/bega.2000.0146_RF59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/clinids\/22.6.997","article-title":"Randomised controlled trial of selective bowel decontamination for prevention of infections following liver transplantation","volume":"22","author":"Arnow","year":"1996","journal-title":"Clinical Infectious Disease"},{"key":"10.1053\/bega.2000.0146_RF60","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/infdis\/170.3.644","article-title":"Risk factors for early invasive fungal infection complicating orthotopic liver transplantation","volume":"170","author":"Collins","year":"1994","journal-title":"Journal of Infectious Disease"},{"key":"10.1053\/bega.2000.0146_RF61","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/00007890-199610150-00010","article-title":"Risk factors of invasive candida and non-candida fungal infections after liver transplantation","volume":"62","author":"Patel","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF62","first-page":"1517","article-title":"Fungal disease in liver transplant recipients: a multivariate analysis of risk factors","volume":"23","author":"Castaldo","year":"1991","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF63","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/174.3.583","article-title":"Randomised trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation","volume":"174","author":"Lumberas","year":"1996","journal-title":"Journal of Infectious Disease"},{"key":"10.1053\/bega.2000.0146_RF64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00007890-199501150-00009","article-title":"Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomised, placebo-controlled study","volume":"59","author":"Tollemar","year":"1995","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF65","first-page":"1826","article-title":"Risk factors for deep fungal infections in liver transplant recipients","volume":"22","author":"Tollemar","year":"1990","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF66","doi-asserted-by":"crossref","first-page":"984","DOI":"10.7326\/0003-4819-119-10-199311150-00004","article-title":"Use of cytomegalovirus immune globulin prophylaxis in liver transplantation: a randomised, double-blind placebo-controlled trial","volume":"119","author":"Snydman","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0146_RF67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(95)92110-9","article-title":"Randomised comparison of ganciclovir and high-dose acyclovir for long-term cytomegalovirus prophylaxis in liver-transplant recipients","volume":"346","author":"Winston","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF68","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007890-198909000-00018","article-title":"The hepatic artery in liver transplantation","volume":"48","author":"Merion","year":"1989","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF69","first-page":"2406","article-title":"Hepatic artery in liver transplantation","volume":"19","author":"Todo","year":"1987","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF70","first-page":"2460","article-title":"Low haematocrit reduces hepatic artery thrombosis after liver transplantation","volume":"21","author":"Buckels","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF71","doi-asserted-by":"crossref","first-page":"S564","DOI":"10.1097\/00007890-199905150-00110","article-title":"Causes of late mortality in survivors of liver transplantation","volume":"67","author":"Sudan","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00007890-199807150-00010","article-title":"Chronic renal failure following liver","volume":"66","author":"Fisher","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF73","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0041-1345(98)00679-4","article-title":"Induction of kidney graft acceptance by creating a window of opportunity for immunologic engagement (WOFIE) in rhesus monkeys","volume":"30","author":"Jonker","year":"1998","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF74","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(94)91766-3","article-title":"Randomised trial comparing tacrolimus and cyclosporin in prevention of liver allograft rejection","volume":"344","author":"Neuhaus","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF76","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus and cyclosporine for immunosuppression in liver transplantation","volume":"331","author":"Busuttil","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF77","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0041-1345(98)00286-3","article-title":"Tacrolimus-based dual versus triple therapy following liver transplantation","volume":"30","author":"Samuel","year":"1998","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF78","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00007890-199808270-00014","article-title":"A long-term comparison of tacrolimus versus cyclosporine in liver transplantation. A report of the United States FK506 study group","volume":"66","author":"Wiesner","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF79","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0041-1345(97)00464-8","article-title":"Three year follow up of the European Multicenter Tacrolimus liver study","volume":"29","author":"Pichlmayer","year":"1997","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF80","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00007890-199560120-00013","article-title":"A randomised prospective trial of steroid withdrawal after liver transplantation","volume":"60","author":"McDiarmid","year":"1995","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00007890-199701270-00012","article-title":"Weaning of immunosuppression in liver transplant recipients","volume":"63","author":"Mazariegos","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF83","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/hep.510270406","article-title":"Defining the outcome of immunosuppression withdrawal after liver transplantation","volume":"27","author":"Devlin","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF84","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00007890-199709150-00011","article-title":"Neoral compared to Sandimmune is associated with a decrease in histological severity of rejection in patients undergoing liver transplantation","volume":"64","author":"Graziadei","year":"1997","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF85","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1097\/00007890-199812270-00011","article-title":"Randomised trial of cyclosporine microemulsion (Neoral) versus conventional cyclosporine in liver transplantation: MILTON study","volume":"66","author":"Otto","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF86","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/00007890-199910270-00021","article-title":"A pilot study of immunosuppressive monotherapy in liver transplantation","volume":"68","author":"Rolles","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1432-2277.1997.tb00690.x","article-title":"Mycophenolate mofetil added to immunosuppression after liver transplantation: first results","volume":"10","author":"Klupp","year":"1997","journal-title":"Transplantation International"},{"key":"10.1053\/bega.2000.0146_RF88","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0041-1345(98)01925-3","article-title":"Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation","volume":"31","author":"Klupp","year":"1999","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00007890-199811270-00024","article-title":"A prospective randomised trial of tacrolimus, prednisolone versus tacrolimus, prednisolone and mycophenolate mofetil in primary adult liver transplant recipients: an interim report","volume":"66","author":"Jain","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00007890-199902270-00002","article-title":"Sirolimus: a potent new immunosuppressant for liver transplantation","volume":"67","author":"Watson","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF91","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00000658-197709000-00006","article-title":"Observations on preservation, bile drainage and rejection in 64 orthotopic liver allografts","volume":"186","author":"Calne","year":"1977","journal-title":"Annals of Surgery"},{"key":"10.1053\/bega.2000.0146_RF92","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/hep.1840140513","article-title":"Reduction of morbidity and mortality from biliary complications after liver transplantation","volume":"14","author":"Klein","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF93","first-page":"170","article-title":"Nonoperative management of biliary tract complications after liver transplantation","volume":"4","author":"LaBerge","year":"1993","journal-title":"Seminars in Gastrointestinal Disease"},{"key":"10.1053\/bega.2000.0146_RF94","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00000658-199401000-00007","article-title":"The incidence, timing and management of biliary tract complications after orthotopic liver transplantation","volume":"219","author":"Greif","year":"1994","journal-title":"Annals of Surgery"},{"key":"10.1053\/bega.2000.0146_RF95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0016-5085(92)91129-R","article-title":"Recurrent and acquired hepatitis C viral infection in liver transplant recipients","volume":"103","author":"Wright","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF96","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(94)90759-5","article-title":"Quantitation of hepatitis C virus RNA in liver transplant recipients","volume":"106","author":"Chazouilleres","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF97","first-page":"1137","article-title":"The curse of hepatitis C infection after liver transplantation","volume":"20","author":"Feray","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF98","first-page":"699","article-title":"The outcome of hepatitis C virus infection after liver transplantation\u2014is it influenced by the type of immunosuppression?","volume":"30","author":"Papatheoridis","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF99","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation: increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/hep.510260236","article-title":"Pilot study of the combination of interferon alpha and ribaviron as therapy of hepatitis C after liver transplantation","volume":"26","author":"Bizollon","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF101","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/hep.510270530","article-title":"A randomised study comparing ribaviron and interferon alpha monotherapy for hepatitis C recurrence after liver transplantation","volume":"27","author":"Gane","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF102","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00007890-199801150-00016","article-title":"Interferon alpha for prophylaxis of recurrent hepatitis C in liver transplant recipients: a prospective, randomised, controlled trial","volume":"65","author":"Singh","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF103","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840220411","article-title":"An open trial of interferon alpha recombinant for hepatitis C after liver transplantation: antiviral effects and risk of rejection","volume":"22","author":"Feray","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF104","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-128-10-199805150-00003","article-title":"Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation","volume":"128","author":"Feray","year":"1998","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.2000.0146_RF105","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histological findings after transplantation for chronic hepatitis B virus infection including a unique pattern of fibrosing cholestatic hepatitis","volume":"13","author":"Davies","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2559.1993.tb01179.x","article-title":"Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis","volume":"23","author":"Harrison","year":"1993","journal-title":"Histopathology"},{"key":"10.1053\/bega.2000.0146_RF107","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/00007890-199304000-00020","article-title":"Steroid withdrawal from long-term immunosuppression in liver allograft recipients","volume":"55","author":"Padbury","year":"1993","journal-title":"Transplantation"},{"key":"10.1053\/bega.2000.0146_RF108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(96)02266-0","article-title":"Hepatitis B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation","volume":"349","author":"Bartholomew","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/bega.2000.0146_RF109","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0168-8278(99)80204-9","article-title":"High pre-treatment serum HBV titre predicts failure of lamivudine prophylaxis and graft reinfection after liver transplantation","volume":"30","author":"Mutimer","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF110","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.510280241","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin","volume":"28","author":"Markowitz","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198201073060101","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation","volume":"306","author":"Neuberger","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.2000.0146_RF112","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0016-5085(89)90643-4","article-title":"Evidence for disease recurrence after liver transplantation for primary biliary cirrhosis: clinical and histological follow up studies","volume":"97","author":"Polson","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.2000.0146_RF113","first-page":"2402","article-title":"Does liver transplantation cure primary biliary cirrhosis?","volume":"21","author":"Buist","year":"1989","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/bega.2000.0146_RF114","first-page":"2654","article-title":"Molecular mimicry in primary biliary cirrhosis","volume":"91","author":"van de Water","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/bega.2000.0146_RF115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0168-8278(05)80244-2","article-title":"Primary biliary cirrhosis: histological evidence of recurrence after liver transplantation","volume":"18","author":"Hubscher","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF116","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.1840180617","article-title":"Histological evidence of recurrence of primary biliary cirrhosis after liver transplantation","volume":"18","author":"Balan","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF117","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","author":"Dmitrewski","year":"1996","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.2000.0146_RF118","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.2000.0146_RF119","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0041-1345(99)00227-4","article-title":"Liver transplantation for autoimmune hepatitis: rejection and recurrence","volume":"31","author":"Narumi","year":"1999","journal-title":"Transplantation Proceedings"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180090146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169180090146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T20:34:49Z","timestamp":1581021289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169180090146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":118,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["S152169180090146X"],"URL":"https:\/\/doi.org\/10.1053\/bega.2000.0146","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}